GenScript is a publicly-traded contract research organization providing gene, peptide, protein, CRISPR, and antibody reagents to global scientists. Since its foundation in 2002, GenScript has grown exponentially through partnerships conducting fundamental and translational biomedical research, as well as early stage pharmaceutical development.